News
Lyon, France-based late-stage clinical biotech MaaT Pharma has presented new preclinical data for MaaT034 at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback